A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
The Scientist
Most Recent
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.
Charges of corruption and cronyism involving research funding have toppled the Balkan nation’s top science official.
After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.
An estimated 360 million Euros from the coffers of EU research funding was spent mistakenly; auditors blame overly complicated funding rules.
European agencies will evaluate a recent study that links genetically modified corn to early death.
A questionable study claims that rats fed approved genetically modified maize developed cancer and died early.
Research and funding organizations pledge to support a new system to support cross-border collaboration within the European Union.
A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
